{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T20:42:18Z","timestamp":1775940138616,"version":"3.50.1"},"reference-count":29,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2022,12,18]],"date-time":"2022-12-18T00:00:00Z","timestamp":1671321600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life"],"abstract":"<jats:p>PRKAG2 syndrome (PS) is a rare, early-onset autosomal dominant phenocopy of sarcomeric hypertrophic cardiomyopathy (HCM), that mainly presents with ventricular pre-excitation, cardiac hypertrophy and progressive conduction system degeneration. Its natural course, treatment and prognosis are significantly different from sarcomeric HCM. The clinical phenotypes of PRKAG2 syndrome often overlap with HCM due to sarcomere protein mutations, causing this condition to be frequently misdiagnosed. The syndrome is caused by mutations in the gene encoding for the \u03b32 regulatory subunit (PRKAG2) of 5\u2032 Adenosine Monophosphate-Activated Protein Kinase (AMPK), an enzyme that modulates glucose uptake and glycolysis. PRKAG2 mutations (OMIM#602743) are responsible for structural changes of AMPK, leading to an impaired myocyte glucidic uptake, and finally causing storage cardiomyopathy. We describe the clinical and investigative findings in a family with several affected members (NM_016203.4:c.905G&gt;A or p.(Arg302Gln), heterozygous), highlighting the various phenotypes even in the same family, and the utility of genetic testing in diagnosing PS. The particularity of this family case is represented by the fact that the index patient was diagnosed at age 16 with cardiac hypertrophy and ventricular pre-excitation while his mother, by age 42, only had Wolff\u2013Parkinson\u2013White syndrome, without left ventricle hypertrophy. Both the grandmother and the great-grandmother underwent pacemaker implantation at a young age because of conduction abnormalities. Making the distinction between PS and sarcomeric HCM is actionable, given the early-onset of the disease, the numerous life-threatening consequences and the high rate of conduction disorders. In patients who exhibit cardiac hypertrophy coexisting with ventricular pre-excitation, genetic screening for PRKAG2 mutations should be considered.<\/jats:p>","DOI":"10.3390\/life12122136","type":"journal-article","created":{"date-parts":[[2022,12,19]],"date-time":"2022-12-19T06:24:44Z","timestamp":1671431084000},"page":"2136","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Intrafamilial Phenotypical Variability Linked to PRKAG2 Mutation\u2014Family Case Report and Review of the Literature"],"prefix":"10.3390","volume":"12","author":[{"given":"Andreea Sorina","family":"Marcu","sequence":"first","affiliation":[{"name":"Expert Center for Genetic Cardiovascular Diseases, Emergency Institute for Cardiovascular Diseases, 258 Fundeni Street, 022328 Bucharest, Romania"},{"name":"Cardiology Department, Emergency Clinical County Hospital Craiova, 1 Tabaci Street, 200642 Craiova, Romania"},{"name":"Department of Cardiology, University of Medicine and Pharmacy Craiova, 2 Petru Rares Street, 200349 Craiova, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7163-8528","authenticated-orcid":false,"given":"Radu","family":"V\u0103t\u0103\u015fescu","sequence":"additional","affiliation":[{"name":"Cardiology Department, Emergency Clinical Hospital Floreasca, 8 Calea Floreasca, 014461 Bucharest, Romania"},{"name":"Department of Cardiothoracic Pathology, University of Medicine and Pharmacy Carol Davila, 8 Eroii Sanitari Blvd., 050474 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Onciul","sequence":"additional","affiliation":[{"name":"Cardiology Department, Emergency Clinical Hospital Floreasca, 8 Calea Floreasca, 014461 Bucharest, Romania"},{"name":"Department of Cardiothoracic Pathology, University of Medicine and Pharmacy Carol Davila, 8 Eroii Sanitari Blvd., 050474 Bucharest, Romania"},{"name":"Emerald Medical Center, 75 Nicolae G. Caramfil Street, 077190 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viorica","family":"R\u0103doi","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, University of Medicine and Pharmacy Carol Davila, 8 Eroii Sanitari Blvd., 050474 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3438-2612","authenticated-orcid":false,"given":"Ruxandra","family":"Jurcu\u0163","sequence":"additional","affiliation":[{"name":"Expert Center for Genetic Cardiovascular Diseases, Emergency Institute for Cardiovascular Diseases, 258 Fundeni Street, 022328 Bucharest, Romania"},{"name":"Department of Cardiothoracic Pathology, University of Medicine and Pharmacy Carol Davila, 8 Eroii Sanitari Blvd., 050474 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,12,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.jacc.2004.11.053","article-title":"Adenosine monophosphate-activated protein kinase disease mimicks hypertrophic cardiomyopathy and Wolff-Parkinson-White syndrome: Natural history","volume":"45","author":"Murphy","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1172\/JCI19874","article-title":"CBS domains form energy-sensing modules whose binding of adenosine ligands is disrupted by disease mutations","volume":"113","author":"Scott","year":"2004","journal-title":"J. Clin. Investig."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1042\/bj3460659","article-title":"Characterization of AMP-activated protein kinase gamma-subunit isoforms and their role in AMP binding","volume":"346","author":"Cheung","year":"2000","journal-title":"Biochem. J."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1172\/JCI0214571","article-title":"Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy","volume":"109","author":"Arad","year":"2002","journal-title":"J. Clin. Investig."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1161\/CIRCGENETICS.110.958835","article-title":"Sarcomere protein gene mutations in patients with apical hypertrophic cardiomyopathy","volume":"4","author":"Gruner","year":"2011","journal-title":"Circ. Cardiovasc. Genet."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1056\/NEJM200106143442403","article-title":"Identification of a Gene Responsible for Familial Wolff\u2013Parkinson\u2013White Syndrome","volume":"344","author":"Gollob","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1056\/NEJMoa033349","article-title":"Glycogen storage diseases presenting as hypertrophic cardiomyopathy","volume":"352","author":"Arad","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1161\/hc5001.102111","article-title":"Novel PRKAG2 mutation responsible for the genetic syndrome of ventricular Preexcitation and conduction system disease with childhood onset and absence of cardiac hypertrophy","volume":"104","author":"Gollob","year":"2001","journal-title":"Circulation"},{"key":"ref_9","first-page":"197","article-title":"Genetic basis and pathogenesis of Familial WPW Syndrome","volume":"3","author":"Sidhu","year":"2003","journal-title":"Indian Pacing Electrophysiol. J."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2152\/jmi.65.1","article-title":"Molecular Pathogenesis of Familial Wolff-Parkinson-White Syndrome","volume":"65","author":"Miyamoto","year":"2018","journal-title":"J. Med. Investig."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e003121","DOI":"10.1161\/CIRCEP.115.003121","article-title":"Clinical Spectrum of PRKAG2 Syndrome","volume":"9","author":"Porto","year":"2016","journal-title":"Circ. Arrhythmia Electrophysiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1161\/CIRCRESAHA.114.302364","article-title":"Mutation in the \u03b32-Subunit of AMP-activated protein kinase stimulates cardiomyocyte proliferation and hypertrophy independent of glycogen storage","volume":"114","author":"Kim","year":"2014","journal-title":"Circ. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1161\/CIRCRESAHA.111.259952","article-title":"AMP-activated protein kinase phosphorylates cardiac troponin I and alters contractility of murine ventricular myocytes","volume":"110","author":"Oliveira","year":"2012","journal-title":"Circ. Res."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Liu, Y., Bai, R., Wang, L., Zhang, C., Zhao, R., Wan, D., Chen, X., Caceres, G., Barr, D., and Barajas-Martinez, H. (2013). Identification of a Novel De Novo Mutation Associated with PRKAG2 Cardiac Syndrome and Early Onset of Heart Failure. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0064603"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.carpath.2009.06.003","article-title":"Inherited cardiomyopathies mimicking arrhythmogenic right ventricular cardiomyo-pathy","volume":"19","author":"Roberts","year":"2010","journal-title":"Cardiovasc. Pathol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jacc.2020.05.029","article-title":"Clinical Features and Natural History of PRKAG2 Variant Cardiac Glycogenosis","volume":"76","author":"Dominguez","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"840337","DOI":"10.3389\/fcvm.2022.840337","article-title":"Atrial Lesions in a Pedigree With PRKAG2 Cardiomyopathy: Involvement of Disrupted AMP-Activated Protein Kinase Signaling","volume":"9","author":"Chen","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"512","DOI":"10.21037\/atm-21-3843","article-title":"Monogenic basis of young-onset cryptogenic stroke: A multicenter study","volume":"10","author":"Yuan","year":"2022","journal-title":"Ann. Transl. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"20610","DOI":"10.1038\/s41598-020-77124-9","article-title":"Phenotypic expression and clinical out-comes in a South Asian PRKAG2 cardiomyopathy cohort","volume":"10","author":"Ahamed","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1093\/ehjci\/jeaa176","article-title":"Glycogen storage cardiomyopathy (PRKAG2): Diagnostic findings of standard and advanced echocardiography techniques","volume":"22","author":"Pena","year":"2020","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e003367","DOI":"10.1161\/CIRCHEARTFAILURE.116.003367","article-title":"Glycogen Storage Disease Because of a PRKAG2 Mutation Causing Severe Biventricular Hypertrophy and High-Grade Atrio-Ventricular Block","volume":"9","author":"Yogasundaram","year":"2016","journal-title":"Circ. Heart Fail."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12968-015-0192-3","article-title":"Cardiovascular magnetic resonance findings in patients with PRKAG2 gene mutations","volume":"17","author":"Hiippala","year":"2015","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1093\/eurheartj\/ehu015","article-title":"Myocardial infarction in a teenager","volume":"35","author":"Sternick","year":"2014","journal-title":"Eur. Heart J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1016\/j.jacc.2013.02.099","article-title":"Cardiac hypertrophy, accessory pathway, and con-duction system disease in an adolescent: The PRKAG2 cardiac syndrome","volume":"62","author":"Fabris","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"102723","DOI":"10.1016\/j.ebiom.2020.102723","article-title":"Identification, clinical manifestation and structural mech-anisms of mutations in AMPK associated cardiac glycogen storage disease","volume":"54","author":"Hu","year":"2020","journal-title":"eBioMedicine"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1086\/430840","article-title":"Fatal congenital heart glycogenosis caused by a recurrent activating R531Q mutation in the gamma 2-subunit of AMP-activated protein kinase (PRKAG2), not by phosphor-ylase kinase deficiency","volume":"76","author":"Burwinkel","year":"2005","journal-title":"Am. J. Hum. Genet."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.hrthm.2010.09.081","article-title":"Clinical, electrocardiographic, and electrophysi-ologic characteristics of patients with a fasciculoventricular pathway: The role of PRKAG2 mutation","volume":"8","author":"Sternick","year":"2011","journal-title":"Heart Rhythm."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.nmd.2005.12.004","article-title":"A new mutation in PRKAG2 gene causing hypertrophic cardiomyopathy with conduction system disease and muscular glycogenosis","volume":"16","author":"Richard","year":"2006","journal-title":"Neuromuscul. Disord."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: The Task Force for the Diagnosis and Management of Hypertrophic Car-diomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Authors","year":"2014","journal-title":"Eur. Heart J."}],"container-title":["Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-1729\/12\/12\/2136\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:43:38Z","timestamp":1760147018000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-1729\/12\/12\/2136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,18]]},"references-count":29,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["life12122136"],"URL":"https:\/\/doi.org\/10.3390\/life12122136","relation":{},"ISSN":["2075-1729"],"issn-type":[{"value":"2075-1729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,18]]}}}